What is ischemic heart disease
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest ischemic heart disease is a group of syndromes caused by an imbalance between the heart's oxygen supply and demand, leading to conditions like angina, myocardial infarction, and heart failure, and it is the leading cause of death globally.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Ischemic Heart Disease
Definition and Pathophysiology of Ischemic Heart Disease
Ischemic heart disease (IHD), also known as coronary artery disease, is a condition characterized by reduced blood flow to the heart muscle due to the narrowing or blockage of the coronary arteries. This imbalance between the heart's oxygen supply and demand leads to myocardial ischemia, which can result in various clinical manifestations ranging from stable angina to acute myocardial infarction and ischemic cardiomyopathy .
Causes and Risk Factors
The primary cause of IHD is atherosclerosis, a process where plaque builds up inside the coronary arteries, leading to their narrowing and reduced blood flow. Other contributing factors include coronary artery stenosis and functional alterations in coronary circulation . Risk factors for developing IHD include hypertension, diabetes mellitus, smoking, high cholesterol levels, and a sedentary lifestyle.
Clinical Presentations
IHD presents in several forms, broadly categorized into acute coronary syndromes (ACS) and chronic coronary syndromes. ACS includes conditions such as unstable angina and acute myocardial infarction, while chronic coronary syndromes encompass stable angina and ischemic cardiomyopathy . Symptoms often include chest pain or discomfort (angina pectoris), shortness of breath, and fatigue.
Diagnostic Techniques
Advancements in imaging technologies have significantly improved the diagnosis of IHD. Noninvasive methods such as coronary computed tomography (CT) angiography and cardiac magnetic resonance (CMR) imaging are now preferred for their ability to provide detailed assessments of coronary artery conditions and myocardial perfusion . These techniques help in tracking the disease progression and planning appropriate treatment strategies.
Treatment Options
Treatment for IHD aims to restore the balance between oxygen supply and demand in the heart muscle. Conventional treatments include lifestyle modifications, pharmacological therapies, and surgical interventions such as coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) . Additionally, biopharmaceutical therapies, including gene therapy and cell transplantation, are emerging as promising approaches to enhance neovascularization and improve blood flow in the ischemic heart.
Prognosis and Management
Optimal medical management remains crucial for patients with IHD. This includes the use of antianginal medications, statins, and antithrombotic agents to stabilize or regress the disease. For patients unresponsive to medical therapy, revascularization procedures guided by fractional flow reserve (FFR) can provide symptom relief and reduce the risk of spontaneous myocardial infarction.
Conclusion
Ischemic heart disease remains a leading cause of morbidity and mortality worldwide. Understanding its pathophysiology, risk factors, and clinical presentations is essential for effective diagnosis and management. Advances in imaging and treatment options continue to improve patient outcomes, offering hope for better management of this pervasive condition.
Sources and full results
Most relevant research papers on this topic
